The global centesis catheters market size was reached at USD 633.00 million in 2026 and is expected to exceed around USD 1,233.62 million by 2035, with a CAGR of 6.9%.

| Report Coverage | Details |
| Market Size in 2025 | USD 676.68 Million |
| Revenue Forecast by 2035 | USD 1,233.62 Million |
| Growth rate from 2026 to 2035 | CAGR of 6.9% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Regions | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | ARGON MEDICAL, Avanos Medical Devices, Axiom Medical, Inc. |
How did the Small-bore Centesis Catheters Segment Dominate the Centesis Catheters Market?
The small-bore centesis catheters segment is driven by the shift toward minimally invasive interventions that prioritise patient comfort and safety. Their leadership is cemented by clinical evidence proving they are as effective as large-bore alternatives while significantly reducing complications like air entry or tissue trauma. Enhanced by Echo-Enhanced Needles for precise ultrasound-guided placement, these devices have become the gold standard for routine thoracentesis and paracentesis.
How did the Paracentesis Segment Account for the Largest Share in the Centesis Catheters Market?
The paracentesis segment is driven by the high global prevalence of liver cirrhosis, hepatitis, and abdominal cancers. Its leadership is sustained by the critical need to manage ascites, a common complication where fluid accumulation causes severe pain and respiratory distress. By utilizing specialized, Pain-Reducing Drainage Catheters, clinicians can perform both diagnostic sampling and therapeutic relief with high safety margins. The use of paracentesis kits as a non-negotiable standard of care for chronic liver disease ensures consistent demand for high-quality paracentesis Kits.
How did the Thoracentesis Segment Expect to hold the fastest-growing Centesis Catheters Market in the Coming Years?
The thoracentesis segment is driven by the shift toward ultrasound-guided thoracentesis and the adoption of low-profile, anti-kink catheters like the Merit Medical Resolve Mini™, which enhance patient comfort in outpatient settings. As healthcare systems in the Asia-Pacific region modernize, the demand for self-sealing, minimally invasive thoracic catheters is reaching record levels to manage chronic respiratory conditions.
How did the Diagnostic Application segment account for the largest share in the Centesis Catheters Market?
The diagnostic application segment is driven by the universal adoption of Small-Bore Catheters, which offer superior safety and reduced risk during high-volume, repetitive sampling procedures. The integration of real-time ultrasound imaging has further enhanced procedural accuracy, allowing clinicians to perform precise fluid extractions even in complex cystic lesions. The primary gateway for early disease intervention, ensuring that diagnostic kits remain the highest-volume product for Becton, Dickinson and Company (BD) and other market leaders.
How did the Therapeutic Application segment expect to hold the fastest-growing Centesis Catheters market in the coming years?
The therapeutic application segment is driven by the rise in Palliative Care and the adoption of advanced, Minimally Invasive One-Step Catheters like the Merit Medical ReSolve Mini™, which maximize patient comfort during long-term fluid management. As healthcare shifts toward Image-Guided Interventions, these specialized tools are becoming essential for alleviating symptoms of refractory ascites and pleural effusions in outpatient settings. The transformation of complex drainage procedures into streamlined, routine therapies that significantly enhance the quality of life for chronically ill patients.
How did the Hospitals Segment Account for the Largest Share in the Centesis Catheters Market?
The hospitals segment is driven by high patient volumes suffering from Gastrointestinal Malignancies and liver cirrhosis, alongside centralized purchasing departments that manage specialized inventories for Becton, Dickinson and Company (BD) and other major suppliers. By providing the specialized medical staff and advanced imaging infrastructure necessary for complex cases, hospitals maintain their status as the primary setting for both diagnostic and palliative fluid management.
How did the ambulatory surgical centres segment expect to hold the fastest-growing Centesis Catheters market in the coming years?
The ambulatory surgical centres segment is emerging as a favourable medicare reimbursement policies and the adoption of one-step valved catheters that allow for safer, streamlined procedures outside of traditional hospitals. As patients increasingly prioritise convenience and lower infection risks, the volume of outpatient thoracentesis and paracentesis is surging across a growing network of certified facilities. The transformation of complex drainage into a routine, accessible service that reduces the financial and operational burden on the broader healthcare system.
By Type
By Procedure
By Application
By End User
By Region